JAMP - Ferrous PolyDextrose 150mg

Natural health product licensed in Canada

Other names: JAMP - Ferrous PolyDextrose
Licence holder: JAMP Pharma Corporation
NPN or DIN-HM: 80112749
Status: Active licence
Licence date: 9 September 2021
Revision date: 14 February 2024
Form: Capsule
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Fer: up to 150 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Fer: up to 150 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSA for adults (40 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Fer Source : Polysaccharide-iron complex	150 mg	150,000 µg

Non-medicinal ingredients

Cellulose microcristalline, Hypromellose, Jaune FD&C n° 6, Bleu FD&C n° 1, D&C Jaune n° 10, Carraghénine, Stéarate de magnésium, Dioxyde de titane, Chlorure de potassium, Rouge FD&C N° 40, Rouge D&C n° 30

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 19 years	1 Capsule	1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency anaemia, form red blood cells and helps in their proper function. Helps to prevent iron deficiency anaemia. Helps to prevent iron deficiency anemia and associated tiredness and fatigue. Helps to prevent iron deficiency. Maintains good health. Mineral supplement. Supports good health. Source of mineral to support biological functions which play a key role in the maintenance of good health.Source of mineral, a factor in normal growth and development.Source of mineral, a factor in the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80112749

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 14 February 2024 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging